45 0 1
Consider this:
Several months back, this stock broke out with wholesale backing along with retail investor enthusiasm over several products in the pipeline with promising outlooks. Since then, about ongoing trials with positive results to date. No bad news regarding any of the pipeline. IBB             correction along with most of the biotech sector in normal back and fill fashion.
Retail investors in somewhat of a dilemma apparently because the stock does not rise in a linear fashion. Wholesale investors still solid holders with what reads as a $1.05 type of basis.
Summary: Same fundamentals with the exception of good news on the ongoing pipeline studies. Retail investors selling, Professionals holding. Judging from minimal volume during sell, we can deduce retail paring of shares and resultant price declines.
I am long this stock for the same reasons I was earlier on.
Resultant huge price increases likely with favorable pipeline results.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out